| 1 |
34904508 | Relationship between baseline clinical characteristics and efficacy of lusutrombopag in thrombocytopenic patients with chronic liver disease: post hoc analysis of two placebo-controlled phase 3 trials. | 2022 Feb |
1 |
| 2 |
33125290 | Human mass balance, metabolism, and cytochrome P450 phenotyping of lusutrombopag. | 2021 Mar |
2 |
| 3 |
33917431 | Thrombocytopenia and Hemostatic Changes in Acute and Chronic Liver Disease: Pathophysiology, Clinical and Laboratory Features, and Management. | 2021 Apr 6 |
1 |
| 4 |
32813292 | Review article: a treatment algorithm for patients with chronic liver disease and severe thrombocytopenia undergoing elective medical procedures in the United States. | 2020 Oct |
1 |
| 5 |
30762895 | Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2). | 2019 Oct |
2 |
| 6 |
31011942 | Management of Thrombocytopenia in Patients with Chronic Liver Disease. | 2019 Oct |
1 |